Hypertriglyceridemia News and Research

RSS
Hypertriglyceridemia refers to the condition where there are high blood levels of triglycerides, the most abundant fatty molecule in most organisms. It has been associated with atherosclerosis, even in the absence of hypercholesterolemia (high cholesterol levels). It can also lead to pancreatitis in excessive concentrations.
Endoscopic sleeve gastroplasty found to be safe and effective way for treating obese patients

Endoscopic sleeve gastroplasty found to be safe and effective way for treating obese patients

ULCA scientists discover how autoantibodies cause some cases of severe hypertriglyceridemia

ULCA scientists discover how autoantibodies cause some cases of severe hypertriglyceridemia

Low normalized grip strength linked to cardiometabolic diseases and disabilities in adults

Low normalized grip strength linked to cardiometabolic diseases and disabilities in adults

Experimental lipid-lowering drug improves glucose control in diabetic patients

Experimental lipid-lowering drug improves glucose control in diabetic patients

First generic version of Crestor gets FDA approval

First generic version of Crestor gets FDA approval

NEJM publishes positive clinical results from Phase 2 clinical study of volanesorsen

NEJM publishes positive clinical results from Phase 2 clinical study of volanesorsen

Blocking the expression of certain gene reduces excessive fat in patients

Blocking the expression of certain gene reduces excessive fat in patients

Infants born with mutation in PLVAP gene develop severe protein losing enteropathy

Infants born with mutation in PLVAP gene develop severe protein losing enteropathy

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

FDA approves CHOLBAM (cholic acid) for treatment of bile acid synthesis disorders

FDA approves CHOLBAM (cholic acid) for treatment of bile acid synthesis disorders

Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

Upregulating heme-oxygenase with hemin helps improve pericardial adipocyte morphology, function

Upregulating heme-oxygenase with hemin helps improve pericardial adipocyte morphology, function

Pembrolizumab shows promising results in patients with classical Hodgkin Lymphoma

Pembrolizumab shows promising results in patients with classical Hodgkin Lymphoma

Ranbaxy obtains FDA approval to manufacture, market Fenofibrate Capsules USP, 43 mg and 130 mg

Ranbaxy obtains FDA approval to manufacture, market Fenofibrate Capsules USP, 43 mg and 130 mg

Phase 3 COU-AA-302 results show ZYTIGA plus prednisone prolongs overall survival in men with chemotherapy-naive mCRPC

Phase 3 COU-AA-302 results show ZYTIGA plus prednisone prolongs overall survival in men with chemotherapy-naive mCRPC

Zydelig gets FDA approval for treatment of patients with three types of blood cancers

Zydelig gets FDA approval for treatment of patients with three types of blood cancers

Alnylam announces new pre-clinical results with DC for ALN-CC5 to treat complement-mediated diseases

Alnylam announces new pre-clinical results with DC for ALN-CC5 to treat complement-mediated diseases

AstraZeneca’s EPANOVA receives FDA approval for treatment of adults with hypertriglyceridemia

AstraZeneca’s EPANOVA receives FDA approval for treatment of adults with hypertriglyceridemia

Alnylam initiates Phase II study with ALN-TTRsc for treatment of ATTR

Alnylam initiates Phase II study with ALN-TTRsc for treatment of ATTR

FDA Advisory Committee recommends metreleptin for treatment of generalized lipodystrophy

FDA Advisory Committee recommends metreleptin for treatment of generalized lipodystrophy